Janssen Sues Mylan, Others To Block Generic Prezista

Law360, New York (June 15, 2012, 2:36 PM EDT) -- Janssen Products LP, a subsidiary of Johnson & Johnson, sued a trio of pharmaceutical companies in New Jersey federal court Wednesday, accusing them of infringing Janssen's patented Prezista and seeking an injunction to stop them from pursuing generic versions of the HIV drug.

Janssen’s complaints allege that attempts by Mylan Pharmaceuticals Inc., Hetero Drugs Ltd., and Teva Pharmaceuticals USA Inc. to produce generic versions of the successful drug violated three patents.

Hetero informed Janssen in February 2011 that it had filed an abbreviated new drug application...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.